Results 141 to 150 of about 373,386 (221)

115. All-trans retinoic acid drug development at the national cancer institute (NCI)

open access: yesBiomedicine & Pharmacotherapy, 1992
DR Parkinson   +4 more
openaire   +1 more source

Crizotinib in Patients with Tumors with MET Amplification or Exon 14 Deletion: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocols C1 and C2. [PDF]

open access: yesClin Cancer Res
Coleman N   +25 more
europepmc   +1 more source

Toward the simultaneous detection of multiple diseases with a highly cost-effective cell-free DNA methylome test. [PDF]

open access: yesProc Natl Acad Sci U S A
Zeng W   +53 more
europepmc   +1 more source

Cancer Treatment-Related Cardiotoxicity among Survivors of Childhood Cancer: A Comparative and Integrated View of Multiple Measures of Biological Age Acceleration. [PDF]

open access: yesCancer Epidemiol Biomarkers Prev
Meng X   +18 more
europepmc   +1 more source

Associations between Perceived Costs and Rewards of Sun Protection and Sun Safety Practices among Rural and Urban High School Students. [PDF]

open access: yesCancer Epidemiol Biomarkers Prev
Anwar OU   +11 more
europepmc   +1 more source

Capturing Latino Health Disparities: Lessons from Mail- and Community-Based Population Health Surveys in California. [PDF]

open access: yesCancer Res Commun
Vang AP   +8 more
europepmc   +1 more source

Effect of metformin on pancreatic neuroendocrine tumors of multiple endocrine neoplasia type 1. [PDF]

open access: yesJ Neuroendocrinol
Kozlov SV   +9 more
europepmc   +1 more source

Discovery of a First-in-Class Murine Double Minute 2-Recruiting Positive Transcription Elongation Factor B PROTAC Degrader With Selective Antitumor Activity. [PDF]

open access: yesMedComm (2020)
Guan X   +16 more
europepmc   +1 more source

Retraction Note: Predicting cancer prognosis and drug response from the tumor microbiome

open access: yesNature Communications
Leandro C. Hermida   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy